We are live on ! Find out more
MHUA

Meihua International Medical Technologies
MHUA

Delisted

MHUA was delisted on the 8th of December, 2025.

Back to rankings

4 hedge funds and large institutions have $73.1K invested in Meihua International Medical Technologies in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

33% less funds holding

Funds holding: 6 → 4 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

85% less capital invested

Capital invested by funds: $489K → $73.1K (-$416K)

Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$59.3K
2
Morgan Stanley
Morgan Stanley
New York
+$6K
3
TRCT
Tower Research Capital (TRC)
New York
+$3.18K
4
UBS Group
UBS Group
Switzerland
+$2.12K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$263K
2
Invesco
Invesco
Georgia
-$180K
3
JP Morgan Chase
JP Morgan Chase
New York
-$7K
4
Osaic Holdings
Osaic Holdings
Arizona
-$6
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$46.9K +$59.3K +168 New
TRCT
2
Tower Research Capital (TRC)
New York
$16.3K +$3.18K +9 +19%
Morgan Stanley
3
Morgan Stanley
New York
$7.94K +$6K +17 +155%
UBS Group
4
UBS Group
Switzerland
$1.88K +$2.12K +6 +600%
Citadel Advisors
5
Citadel Advisors
Florida
– -$263K -391 Closed
Invesco
6
Invesco
Georgia
– -$180K -278 Closed
JP Morgan Chase
7
JP Morgan Chase
New York
– -$7K -10 Closed
Osaic Holdings
8
Osaic Holdings
Arizona
– -$6 – –

MHUA Hedge Fund Activity: Q2 2023 in Review

4 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Meihua International Medical Technologies (MHUA) for Q2 2023, worth a combined $73.1K — down 85% from $489K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of MHUA and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 3 added.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $59.3K. The largest seller was Citadel Advisors, exiting entirely with an estimated $263K sold.

  • 4 institutional investors held Meihua International Medical Technologies (MHUA) as of Q2 2023, down from 6 in Q1 2023.
  • Funds reported $73.1K of Meihua International Medical Technologies stock for Q2 2023, down 85% quarter-over-quarter.
  • 1 fund opened new Meihua International Medical Technologies positions in Q2 2023 and 3 closed out, a net change of -2 holders.
  • The largest Meihua International Medical Technologies buyer in Q2 2023 was Geode Capital Management, an estimated $59.3K added.
  • The largest Meihua International Medical Technologies seller in Q2 2023 was Citadel Advisors, an estimated $263K sold.

Based on aggregated 13F filings for Q2 2023.